Tech

Tech

Technology, AI, platforms, chips, and the race to define the next digital order.

Stories available
7155
Full section coverage

Latest in Tech

Tech
Image unavailable
TechDraft

Software developer Andrew Gallant reports significant recovery after anti-NMDA receptor encephalitis diagnosis

Andrew Gallant, a software developer, has been diagnosed with anti-NMDA receptor encephalitis, an autoimmune disorder causing brain inflammation. Gallant described experiencing flu-like symptoms, severe anxiety, psychosis, and balance issues before being misdiagnosed with a psychiatric condition. After being transferred to Brigham and Women’s Hospital in Boston, he received treatment with intravenous immunoglobulin and steroids, leading to significant recovery. He is currently participating in the CIELO clinical trial for satralizumab and reports a positive prognosis.